Ian Cameron Nicholson

Title: Ian Cameron Nicholson: Innovator in Protein Binding Technologies

Introduction

Ian Cameron Nicholson is a notable inventor based in Highbury, Australia. He has made significant contributions to the field of protein binding technologies, particularly through his innovative patent work. His expertise and dedication to research have positioned him as a key figure in his industry.

Latest Patents

Ian Cameron Nicholson holds a patent titled "Proteins that bind PI16 and uses thereof." This patent describes an isolated protein that includes at least one antibody variable region capable of binding to peptidase inhibitor 16 (PI16). The protein is designed to competitively inhibit the binding of an antibody produced by a hybridoma designated CRCBT-02-001, which is deposited with the ATCC under Accession Number PTA-10685. The invention also outlines various applications for the protein, including its use in diagnosis, therapy, or isolating cells, particularly Treg cells.

Career Highlights

Ian is associated with Medvet Science Pty Ltd, where he applies his expertise in protein technologies. His work at the company has been instrumental in advancing research and development in the field. He has demonstrated a strong commitment to innovation and scientific progress.

Collaborations

Ian collaborates with talented professionals in his field, including Simon Barry and Doreen Krumbiegel. These partnerships enhance the research and development efforts at Medvet Science Pty Ltd, fostering a collaborative environment that drives innovation.

Conclusion

Ian Cameron Nicholson is a distinguished inventor whose work in protein binding technologies has significant implications for medical science. His contributions through patents and collaborations continue to influence the field positively.